These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8888734)
21. A heat shock-like protein from the human malaria parasite Plasmodium falciparum induces autoantibodies. Mattei D; Scherf A; Bensaude O; da Silva LP Eur J Immunol; 1989 Oct; 19(10):1823-8. PubMed ID: 2479563 [TBL] [Abstract][Full Text] [Related]
22. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647 [TBL] [Abstract][Full Text] [Related]
23. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Cooper JA; Cooper LT; Saul AJ Mol Biochem Parasitol; 1992 Apr; 51(2):301-12. PubMed ID: 1574088 [TBL] [Abstract][Full Text] [Related]
24. The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. Gamain B; Miller LH; Baruch DI Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2664-9. PubMed ID: 11226296 [TBL] [Abstract][Full Text] [Related]
25. Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA. Ahlborg N; Iqbal J; Björk L; Ståhl S; Perlmann P; Berzins K Exp Parasitol; 1996 Mar; 82(2):155-63. PubMed ID: 8617342 [TBL] [Abstract][Full Text] [Related]
26. Anti-MSP1 block 2 antibodies are effective at parasite killing in an allele-specific manner by monocyte-mediated antibody-dependent cellular inhibition. Galamo CD; Jafarshad A; Blanc C; Druilhe P J Infect Dis; 2009 Apr; 199(8):1151-4. PubMed ID: 19284307 [TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. Chulay JD; Lyon JA; Haynes JD; Meierovics AI; Atkinson CT; Aikawa M J Immunol; 1987 Oct; 139(8):2768-74. PubMed ID: 3309058 [TBL] [Abstract][Full Text] [Related]
28. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Dutta S; Haynes JD; Barbosa A; Ware LA; Snavely JD; Moch JK; Thomas AW; Lanar DE Infect Immun; 2005 Apr; 73(4):2116-22. PubMed ID: 15784553 [TBL] [Abstract][Full Text] [Related]
29. Antibodies to the major merozoite surface coat protein of Plasmodium falciparum (gp195) in a human population living in a malaria-endemic area of the Philippines. Kramer KJ; Oberst R Am J Trop Med Hyg; 1992 Oct; 47(4):429-39. PubMed ID: 1443339 [TBL] [Abstract][Full Text] [Related]
30. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195. Hui GS; Chang SP; Gibson H; Hashimoto A; Hashiro C; Barr PJ; Kotani S J Immunol; 1991 Dec; 147(11):3935-41. PubMed ID: 1940375 [TBL] [Abstract][Full Text] [Related]
31. Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes. Hui G; Hashimoto C Vaccine; 2007 Jan; 25(5):948-56. PubMed ID: 17023096 [TBL] [Abstract][Full Text] [Related]
32. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development. Yuen D; Leung WH; Cheung R; Hashimoto C; Ng SF; Ho W; Hui G Vaccine; 2007 Jan; 25(3):490-9. PubMed ID: 16949181 [TBL] [Abstract][Full Text] [Related]
33. Plasmodium berghei XAT: protective 155/160 kDa antigens are located in parasitophorous vacuoles of schizont-stage parasite. Kobayashi F; Waki S; Niikura M; Tachibana M; Tsuboi T; Torii M; Kamiya S Exp Parasitol; 2007 Aug; 116(4):450-7. PubMed ID: 17442306 [TBL] [Abstract][Full Text] [Related]
34. [Preparation and characterization of monoclonal antibodies against erythrocyte-binding antigen 175 of Plasmodium falciparum]. Hao WB; Hong YH; Sun XM; Ning Y; Zhang DM; Pan WQ; Li M Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1169-71. PubMed ID: 16174591 [TBL] [Abstract][Full Text] [Related]
35. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum. Kara U; Pye D; Lord R; Pam C; Gould H; Geysen M; Jones G; Stenzel D; Kidson C; Saul A J Immunol; 1989 Aug; 143(4):1334-9. PubMed ID: 2473129 [TBL] [Abstract][Full Text] [Related]
36. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence. Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134 [TBL] [Abstract][Full Text] [Related]
38. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design. Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710 [TBL] [Abstract][Full Text] [Related]
39. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439 [TBL] [Abstract][Full Text] [Related]
40. Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum. Hui GS; Hashimoto A; Chang SP Infect Immun; 1992 Apr; 60(4):1422-33. PubMed ID: 1548068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]